Brand: Adequan
$83.99 $84.99Adequan® Canine (polysulfated glycosaminoglycan) is an FDA-approved injectable medication designed to manage non-infectious degenerative and/or traumatic arthritis in dogs' synovial joints. Administered intramuscularly, it helps alleviate joint pain and inflammation, promoting improved mobility and quality of life.
Adequan® Canine (polysulfated glycosaminoglycan) is a prescription injectable solution formulated to control signs associated with non-infectious degenerative and/or traumatic arthritis in canine synovial joints. Each milliliter contains 100 mg of polysulfated glycosaminoglycan. The recommended dosage is 2 mg per pound (4.4 mg/kg) of body weight, administered intramuscularly twice weekly for up to four weeks, totaling a maximum of eight injections. This regimen aims to reduce joint pain and inflammation, thereby enhancing mobility and overall well-being in affected dogs. Adequan® Canine should not be used in dogs with known hypersensitivity to polysulfated glycosaminoglycan or those with known or suspected bleeding disorders. Regular veterinary consultations are essential to monitor the dog's response to treatment and adjust the therapeutic approach as needed.
© 2024 A2Z Pets Made With By VBE Services.